Refine search

Search Application

Search term:

Results 1 - 4 of 4

EC Number	Application	Commentary	Reference
2.3.1.56	medicine	-	487253
2.3.1.56	medicine	bioactivation of N-hydroxy-2-acetylaminofluorenes by N,O-acytransfer resulting in mutagenic and carcinogenic compounds, DNA adduct formation	487254
2.3.1.56	medicine	important for the activation of urinary metabolites of carcinogenic arylamines for the initiation of bladder carcinogenesis in the dog	487253
2.3.1.56	medicine	metabolic activation by isoforms 1 and 2 of 3-nitrobenzanthrone and N-acetyl-N-hydroxy-3-aminobenzantrone, 2 compounds with high mutagenic and genotoxic potential, formation of DNA adducts	487251

Results 1 - 4 of 4

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)